Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin

Bilal Chughtai1, Robert Levin2, Elise De11Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USAAbstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe community. OAB affects 16% of the adult population an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bilal Chughtai, Robert Levin, Elise De
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Darfenacin Overactive Bladder Urge Incontinence Older patients Aging Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/c7c20afaace947c19801ad9d191f0c5a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c7c20afaace947c19801ad9d191f0c5a
record_format	dspace
spelling	oai:doaj.org-article:c7c20afaace947c19801ad9d191f0c5a2021-12-02T00:16:51ZChoice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin1178-1998https://doaj.org/article/c7c20afaace947c19801ad9d191f0c5a2008-09-01T00:00:00Zhttps://www.dovepress.com/choice-of-antimuscarinic-agents-for-overactive-bladder-in-the-older-pa-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Bilal Chughtai1, Robert Levin2, Elise De11Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USAAbstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe community. OAB affects 16% of the adult population and rises with increasing age. We describe the necessary steps in evaluation and behavioral therapy prior to initiating medical therapy. There are several medications that have been used for the treatment of patients who suffer from OAB. This manuscript discusses the popular agents used for OAB, with a focus on the recent clinical trials on darifenacin.Keywords: darifenacin, overactive bladder, urge incontinence, older patients, agingBilal ChughtaiRobert LevinElise DeDove Medical PressarticleDarfenacinOveractive BladderUrge IncontinenceOlder patientsAgingGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 3, Pp 503-509 (2008)
institution	DOAJ
collection	DOAJ
language	EN
topic	Darfenacin Overactive Bladder Urge Incontinence Older patients Aging Geriatrics RC952-954.6
spellingShingle	Darfenacin Overactive Bladder Urge Incontinence Older patients Aging Geriatrics RC952-954.6 Bilal Chughtai Robert Levin Elise De Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
description	Bilal Chughtai1, Robert Levin2, Elise De11Albany Medical College, Division of Urology; 2Albany College of Pharmacy and Stratton VAMC, Albany, NY, USAAbstract: Overactive bladder (OAB) is a difficult condition to live with and is very costly tothe community. OAB affects 16% of the adult population and rises with increasing age. We describe the necessary steps in evaluation and behavioral therapy prior to initiating medical therapy. There are several medications that have been used for the treatment of patients who suffer from OAB. This manuscript discusses the popular agents used for OAB, with a focus on the recent clinical trials on darifenacin.Keywords: darifenacin, overactive bladder, urge incontinence, older patients, aging
format	article
author	Bilal Chughtai Robert Levin Elise De
author_facet	Bilal Chughtai Robert Levin Elise De
author_sort	Bilal Chughtai
title	Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
title_short	Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
title_full	Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
title_fullStr	Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
title_full_unstemmed	Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
title_sort	choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin
publisher	Dove Medical Press
publishDate	2008
url	https://doaj.org/article/c7c20afaace947c19801ad9d191f0c5a
work_keys_str_mv	AT bilalchughtai choiceofantimuscarinicagentsforoveractivebladderintheolderpatientfocusondarifenacin AT robertlevin choiceofantimuscarinicagentsforoveractivebladderintheolderpatientfocusondarifenacin AT elisede choiceofantimuscarinicagentsforoveractivebladderintheolderpatientfocusondarifenacin
_version_	1718403827813580800

Choice of antimuscarinic agents for overactive bladder in the older patient: focus on darifenacin

Ejemplares similares